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SUMMARY
Infection-associated immunoincompetence during malaria
might result from macrophage dysfunction. In the present
study, we investigated the role of macrophages as target for
immunosuppression during infection, using the murine
Plasmodium c. chabaudi model. Special attention has been
paid to the analysis of processing/presentation of protein
antigens and presentation of peptides, using cocultures of
peritoneal exudate cells (PECs) from infected mice and
antigen-specific T-cell hybridomas. The results obtained
indicate a defective processing of protein antigens that
becomes maximal at acute parasitemias. In addition, macro-
phages from acutely infected mice suppress the interleukin-
2 production by the antigen-activated T-cell hybridomas.
This effect was independent of prostaglandin and nitric
oxide production by the macrophage. The possible role of
parasite components in the impaired accessory cell function
of PECs was investigated and hemozoin, the end-product of
the hemoglobin catabolism by intraerythrocytic malaria
parasites, was found to induce similar infection-associated
deficiencies in vitro. Moreover, hemozoin, was shown to
mimic the immunosuppressive effects induced in PECs
during in-vivo infections with P. chabaudi. In conclusion,
we propose that hemozoin is a key factor in the malaria-
associated immunosuppression, affecting both the antigen
processing and immunomodulatory functions of macro-
phages.
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INTRODUCTION
The occurrence of malaria-associated immunosuppression is
supported by extensive experimental data. Plasmodium
infections have been shown to induce alterations in
immune reactivity and acute malaria has been associated
with increased susceptibility to Salmonellosis (Bennett &
Hook 1959, Mabey et al. 1987) and other bacterial infec-
tions (Greenwood 1974). In addition, reactivation of chronic
and latent viral infections such as Herpes zoster (Cook
1985), H. simplex (Scott 1944) and Epstein–Barr virus
(Whittle et al. 1984, 1990) were found to occur during
acute Plasmodium infections. To date, no single mechanism
can explain the suppressive effects of malaria infections on
the host immune system but early studies in vivo have
suggested that defects in macrophage accessory cell func-
tion could account for the poor immune reactivity (Loose
et al. 1972, Warren & Weidanz 1976, Kim et al. 1978,
Brown & Kreier 1986). Furthermore, macrophages may also
act as immunosuppressor cells (Correa et al. 1980, Mahajan
et al. 1986) during high levels of parasitemias, although the
outcome of this immunomodulatory effect is still unknown.
Experiments in which the lymphoproliferative responses of
splenocytes to mitogens were evaluated have associated the
immunosuppressive effects with nitric oxide (NO) and
prostaglandin production (Rocket et al. 1994, Ahvazi et al.
1995).
Concerning the Plasmodia components responsible of the
immunosuppressive effects, the most marked suppression
has been described for crude schizont extracts and soluble
exoantigens (Riley et al. 1988, Ho et al. 1986, Hviid et al.
1991). It has been also suggested that accumulation of
parasite-derived hemozoin (malaria pigment) inside macro-
phages may inhibit their normal accessory cell functions,
although the mechanism by which the suppression is
mediated has not been characterized (Morakote & Justus
1988).
In the present study, we further analysed the effect
of malaria infections on the accessory cell function of
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peritoneal macrophages. A convenient in-vitro antigen-
presentation system, with a relevant T-cell hybridoma as a
interleukin (IL)-2 producer effector cell was used to dis-
criminate antigen processing from peptide presentation. We
show that acute malaria infections affect the accessory cell
function of macrophages through a defective antigen-
processing and active suppression of IL-2 production by
the T cell hybridoma. The inhibitory effect of the Plasmo-
dium infection involves hemozoin, which readily accumu-
lates within macrophages and which can mimic in vitro the
effect of the malaria infection.
MATERIALS AND METHODS
Mice and parasites
Inbred female Balb/c mice aged 8–12 weeks were pur-
chased from Harlan (Zeist, The Netherlands). The Plasmo-
dium c. chabaudi AS strain was originally obtained from Dr
Walliker (Edinburgh, UK). Parasites were kept as glycerol
(10%) stocks at – 808C or in liquid nitrogen. Infection of
Balb/c mice with the P. c. chabaudi strain is characterized
by a primary peak of parasitemia (28–35%) that is resolved
and followed by one or two minor peaks.
Experimental mice were inoculated intravenously with
1 · 105 infected redblood cells (iRBC). Parasites were
maintained by weekly passages of 105–106 iRBC (diluted
in phosphate buffered saline, PBS) injected intravenously
into Balb/c mice. Parasitemias were determined by exam-
ination of Giemsa-stained (10% in PBS) thin blood smears
and calculated as the percentage of iRBC (% Parasitemia).
For the isolation of trophozoite-infected redblood cells
during day time, infected mice were kept in an inverse
light schedule.
T-cell hybridomas and antigens
The murine 1E5.11 T-cell hybridoma (I-Ed restricted),
reactive to hen egg white lysozyme (HEL) or to the HEL
peptide (residues 150–120) was kindly provided by Dr A.
Darji (GBF, Braunschweig, Germany). Hen egg white
lysozyme (Merck) was used at a final concentration of
10 mg/ml. The HEL peptide (Dr A. Darji) was used at a
final concentration of 5 mg/ml.
Antigen assays
Resident peritoneal exudate cells (PECs) were recovered
from the peritoneal cavity of mice by washing with 10 ml of
an ice cold 0·34 M sucrose solution. The cells were kept in
complete medium supplemented with 2-mercapthoethanol
(RPMI 1640 (Gibco Brl, Life Technologies, Rockville, MD,
USA) þ 10% FCS, 2 mM L-glutamine (Gibco), 5 · 10–5 M 2-
ME (Sigma, St Louis, MO, USA), 100 U/ml of penicillin-
streptomycin (Gibco). PECs were plated into 96-well
plates (Falcon, Becton Dickinson, Franklin Labs, NY,
USA), 100 ml per well, and the cells were allowed to
adhere for 4 h. In certain experiments, nonadherent
cells were removed by washing with warm RPMI. The
1E5.11 T-cell hybridoma was used at a concentration of
2 · 105 cells/ml, 100 ml per well. The antigens were added
at the concentrations described above. Eighteen hours
later, the supernatants were recovered and assayed for
IL-2.
The porphyrins b-hematin and hemozoin were used at a
final concentration of 10 mg/ml, and were added to the PECs
prior to the addition of the T-cell hybridoma and the
antigens.
Fixation with glutaraldehyde
The PECs were washed and resuspended to 4 · 106 cells/ml.
A hundred microliters of a 0·5% glutaraldehyde (GA)
solution in PBS were added to 1 ml of the cell suspension
and 45 s later the cells were washed in an excess of PBS four
times. The pellet was resuspended in complete medium. The
fixed PECs were used as antigen presenting cells (APC) with
the HEL peptide and the 1E5.11 T-cell hybridoma.
In certain experiments, PECs were preincubated with
lysozyme (10 mg/ml) for 3 h, excess antigen was removed
by washing, and the cells were recovered in suspension and
fixed with GA as described above.
Hemozoin and b-hematin
Crude hemozoin was obtained from the blood of P. c.
chabaudi-infected Balb/c mice. Mice with a parasitemia of
25% or more were bled when trophozoites were the pre-
dominant malaria blood form. After two washes in ice-cold
PBS, the white blood cells were eliminated by passage of the
blood through a column of sulphoethylcellulose (Serva,
Heidelberg, Germany): sephadex G25 (Pharmacia, Uppsala,
Sweden) (1 : 3 w/w in PBS). The trophozoite containing
iRBC were washed twice and lysed by sonication with a
soniprep 150 (1 min bursts/1 min cooling/200–300 W).
Crude hemozoin, characterized by a brownish pellet, was
obtained after exhaustive washes to eliminate free hemo-
globin. After a final wash in 70% ethanol, the crude
hemozoin was vacuum dried.
Chemically synthesized b-hematin was prepared as
described (Fitch & Kanjananggulpan 1987). Briefly, 60
mmol of hematin (Sigma) were dissolved in 8 ml of 0·1 M
NaOH, under N2, and the porphyrin was precipitated by the
addition of 49 mmol of acetic acid. The suspension was
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heated overnight at 708C and the precipitate was washed
four times in distilled water. Non reacting hematin was
removed by extracting the precipitate twice for 3 h in 0·1 M
sodium bicarbonate buffer, pH 9·1. The remaining insoluble
material was recovered by centrifugation, and washed four
times in distilled water. After a final wash in 70% ethanol,
the insoluble material was air-dried. This method routinely
converts 40–50% of the starting material into b-hematin
(Slater et al. 1991). b-hematin and crude hemozoin (weight
as a powder when dried) were resuspended in RPMI at a
concentration of 1 mg/ml. To facilitate the treatment of the
PECs with insoluble hemozoin or b-hematin, the compounds
were then mechanically microdispersed and sonicated.
Measurements of hemozoin in PECs
PECs from noninfected and P. chabaudi-infected (25%
parasitemia) mice were isolated as previously described
and washed in PBS. The cells were lysed by three freeze-
thaw cycles. Hemozoin levels in the cell lysates were
measured based on the property of haem-elicited luminis-
cence (Schwarzer et al. 1994). 100 ml luminol/NaOH solu-
tion (luminol, 1 mg/ml) (Sigma), dissolved in a NaOH
solution containing 0·1 M NaOH and 3 mM ethylenediami-
netetraacetic acid (EDTA), and 100 ml t-buthylhydro-
peroxide/NaOH solution (7·26 mM t-buthylhydroperoxide
(Sigma), dissolved in a solution containing 0·1 M NaOH
and 3 mM EDTA), were mixed in a 96-well plate. Serial
dilutions of PECs lysate (30 ml/well) were added to the plate
and luminescence ouput was immediately measured at
530 nm and maximal gain, using a Cytofluor II fluorescent
multiwell plate reader (PerSeptive Biosystems, Framingham,
MA, USA). Results were plotted as flourescent units
in function of cell concentration. As a control, synthetic
b-hematine was used.
IL-2-specific enzyme-linked immunosorbent assay
96-well plates (Nunc, Roskilde, Denmark) were coated with
the rat antimouse IL-2 monoclonal antibody (18161D,
Pharmingen, San Diego, CA, USA) (0·05 mg/ml in 0·1 M
sodium hydrogen carbonate, pH 9·6), overnight at 48C. After
two washes in PBS þ 0·05% Tween 20, the plates were
blocked with PBS þ 10% FCS (Gibco) for 2 h at 378C.
Subsequently, the wells were incubated with 100 ml of
supernatants from the antigen presentation tests (triplicates),
or with 100 ml of a recombinant murine IL-2 standard
(19211T, Pharmingen, diluted in PBS þ 10% FCS) for 1 h
at 378C. Following four washes, 100 ml of the biotinilated rat
antimouse IL-2 monoclonal antibody (18172D, Pharmin-
gen) (0·05 mg/ml in PBS þ 10% FCS) were applied into each
well, and allowed to react for 1 h at 378C. A hundred
microliters of streptavidin-peroxidase conjugate (Jackson
Immuno Research, West Grove, PA, USA) (0·025 mg/ml in
PBS þ 10% FCS) were added for 30 min. Once the plates
were washed several times, the bound complexes were
detected by reaction with tetramethyl-benzidine (TMB,
Sigma) and H2O2. The absorbencies were read at 450 nm/
690 nm and the IL-2 concentration in the samples was
calculated as pg/ml using the recombinant murine IL-2
standard. Statistical analysis of the experimental data was
performed using Student’s t-test.
Uptake and catabolism of protein antigen
Lysozyme was radiolabelled with 125I (to a specific activity
of 1·1106–4·7106 cpm/mg) as specified by the manufacturer
(Pierce Chemicals, Rockford, IL, USA). PECs (2106 per ml)
were plated on 35 mM tissue culture plates (Falcon) and
incubated with 6 mg of radiolabeled lysozyme for 4 h at 378C.
Non-adherent PECs and nonincorporated lysozyme were
removed by washing the culture plates with warm RPMI
several times until no radioactivity could be detected in the
washing medium. The adherent PECs were then solubilized
in Triton X-100 (0·5% in PBS) and the radioactivity from
the total cell extracts was measured. To study protein
catabolism, cells incubated with the radioactive lysozyme
for 4 h were lysed with Triton X-100 and the 10% TCA-
soluble and insoluble radioactivity present in cells and
in culture media were measured. In control experiments,
PECs were incubated with 125I-lysozyme in the presence of
0·2 mM sodium azide to block endocytosis. Statistical ana-
lysis of the experimental data was performed using ANOVA.
RESULTS
Peritoneal antigen-presenting cells from P. chabaudi-
infected exhibit a defective accessory cell function that
correlates with the level of parasitemia
PECs harvested from Plasmodium chabaudi-infected mice
(early, moderate and acute infections) were tested for their
capacity to process/present the lysozyme protein or to
present a lysozyme-derived peptide (HELpep residues
105–120) to a relevant T-cell hybridoma (1E5.11). The
results shown in Table 1 indicate that during P. chabaudi
infections, PECs become gradually defective in their ability
to stimulate, via antigen processing/presentation, IL-2 pro-
duction by a relevant T-cell hybridoma. Indeed, at moderate
parasitemias, a reduced IL-2 production is recorded when
assessing processing/presentation of lysozyme and an
increase in parasitemia concomitantly causes a further
impairment in IL-2 production by the T-cell hybridoma.
When testing presentation of the HEL-peptide, a significant
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defective IL-2 production also is observed at high
parasitemias.
The parasite-derived factor hemozoin causes a
deficient accessory cell function in PECs
The observation that acute malaria infections induced a
defective accessory cell function in peritoneal antigen-
presenting cells, led us to investigate whether in-vitro
treatment of naive PECs with malaria parasite products
could induce a similar cellular dysfunction. Peritoneal
macrophages from noninfected mice incubated with crude
hemozoin, readily ingested and accumulated the malaria
pigment (observed under the light microscope as a dark-
brown product retained within the cytoplasm of the
phagocyte). The engulfed hemozoin persisted within the
cells for at least 72 h, but did not kill the cells (the viability
was assessed by trypan blue staining), nor alter their
adherence properties. Similar features were observed when
PECs were incubated with b-hematin, the synthetic form of
hemozoin (results not shown).
PECs loaded with crude hemozoin were severely affected
in their ability to activate the 1E5.11 T-cell hybridoma
via protein antigen processing/presentation or peptide
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Table 1 Peritoneal antigen-presenting cells from P. chabaudi-infected mice are suppressed in their capacity to induce IL-2 production by relevant
T-cell hybridomas. The defective accessory cell function correlates with the level of parasitemia
IL-2 production (pg/ml)
Stimulation with HEL Stimulation with HEL-peptide
% Reduction in IL-2 % Reduction in IL-2
% Parasitemia PECsa · 104/well Control Infected mice productionb Control Infected mice productionb
2 2·5 689 6 42 623 6 65 10 849 6 85 790 6 63 7
1·25 471 6 36 385 6 53 18 646 6 53 655 6 42 0
15 2·5 780 6 53 650 6 39 17 910 6 76 820 6 56 10
1·25 630 6 33 415 6 45 34 580 6 42 520 6 73 10
36 2·5 507 6 45 92 6 23 82 612 6 56 165 6 45 73
1·25 457 6 32 114 6 40 75 457 6 65 246 6 42 46
aPeritoneal exudate cells (PECs) were harvested from non-infected or P. chabaudi AS-infected mice at different days of infection. The PECs were
co-cultured with the 1E5.11 T-cell hybridoma in the presence of hen egg white lysozyme (HEL, 10 mg/ml) or a derived peptide (5 mg/ml).
Eighteen hours later, supernatants from the culture cells were recovered, and their content in IL-2 was estimated by enzyme-linked immunosorbent
assay. Background IL-2 values, in the absence of antigen were zero. Values are expressed as means of triplicate measurements 6 SD.
b% Reduction ¼ (IL-2 concentration (infected mice)]/[IL-2 concentration (control mice)]) · 100.
IL-2 production (pg/ml) % Reduction in IL-2 production
PECs · 104/well HEL HELpep HEL HELpep
Control
2·5 725 6 54 716 6 43
1·25 470 6 28 632 6 32
Hemozoin-treateda
2·5 220 6 9·5 221 6 11 70 69
1·25 190 6 18 247 6 19 59 61
b-hematin treatedb
2·5 80 6 6 64 6 4 89 91
1·25 55 6 8 10 6 5 88 98
a,bPECs were plated in 96-well plates, and crude hemozoin (trophozoite lysate) or synthetic
b-hematin were added at a final concentration of 10 mg/ml, prior to the addition of the T-cell
hybridoma lysozyme (HEL) or the HELpeptide. Values are expressed as means of triplicate
measurements 6 SD.
Table 2 Hemozoin is the parasite-derived factor
involved in the deficient accessory cell
function. In-vitro treatment with crude or
synthetic hemozoin induces a defective
activation of the T-cell hybridomas by
peritoneal antigen-presenting cells
presentation (Table 2). A more pronounced effect was
attained when using synthetic b-hematin. The reduction in
IL-2 production by the T-cell hybridoma was not due to
toxic effects since neither crude hemozoin nor the synthetic
b-hematin interfered with the proliferation of the T-cell
hybridoma (results not shown).
Hemozoin-treated PECs can be conveniently used as an
in-vitro model for the analysis of in-vivo effects of malaria
infections on the antigen-presenting capacity of PECs. The
hemozoin content of PECs from both noninfected and
infected mice was measured by a quantitative haem-
enhanced luminescence method (Schwarzer et al. 1994).
The results presented in Figure 1 show that indeed PECs
from infected mice contain high levels of hemozoin, while
PECs from control mice do not.
The defective accessory cell function of PECs from
P. chabaudi-infected mice is not due to an impaired
uptake and catabolism of protein antigens
The defective activation of the T-cell hybridoma by PECs
from P. chabaudi-infected mice when using protein antigen
could reflect the incapacity of such PECs to take up and
process antigens. To test this possibility, normal PECs and
PECs from P. chabaudi-infected mice (32–38% parasite-
mia) were incubated with radiolabeled HEL and the uptake
and catabolism of the protein was followed. Peritoneal
exudate cells from P. chabaudi acutely infected mice
incorporated radiolabeled lysozyme as efficiently as
normal PECs, and were similarly capable to degrade the
protein. No significant differences were observed between
the efficiency of control PECs and PECs from infected mice
or hemozoin-treated PECs, at the level of protein uptake and
degradation protein (P> 0·05) (Table 3).
The defective accessory cell function of PECs is not
due to an impaired antigen presentation capacity
Activation of a T-cell hybridoma by peritoneal antigen-
presenting cells requires a proper processing of protein
antigens, and a presentation of the antigenic peptides in
the context of MHC class II molecules. The suboptimal IL-2
production by the 1E5.11 T-cell hybridoma was not due to
an incapacity of the PECs from P. chabaudi-infected mice
to present appropriately the antigenic peptide on their sur-
face. Indeed, fixation by GA treatment of PECs from
P. chabaudi-infected mice, prior to addition of the HEL
peptide yielded a similar IL-2 production as control
PECs (Figure 2a,b). Similarly, fixation of hemozoin and
b-hematin treated PECs rendered these cells capable of
inducing IL-2 levels by the T-cell hybridoma comparable
to control PECs (Figure 2a,b).
By treating the PECs with GA after incubation with
lysozyme, processing of the antigen is allowed to occur
and eventually presentation of derived antigenic peptides on
the surface of the antigen-presenting cells. Following this
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Figure 1 Presence of hemozoin in lysate of malaria infected mice. (a)
Cell lysates of PECs isolated from P. chabaudi-infected mice (B) and
non infected control mice (A) were analysed for their hemozoin
content, by haem-enhanced fluorescence. Results of triplicate
measurements are expressed as fluorescent units (mean 6 SD), and
(b) compared to the fluorescent signal obtained with synthetic b-
hematin (X).
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treatment, PECs from acutely infected mice were still
impaired in their capacity to activate optimally the 1E5.11
T-cell hybridoma (Figure 2c,d). This result indicates that the
malaria infection affects the late stage processing of proteins
by PECs. Similar results were obtained with hemozoin and
b-hematin treated PECs pulsed with lysozyme (Figure 2c,d).
The defective accessory cell function of PECs from
infected mice does not involve prostaglandins or nitric
oxide
GA fixation of PECs from infected mice and pulsing with
the HEL peptide led to normal IL-2 production by the T-cell
hybridoma. Therefore it was further investigated whether
when viable, the cells produced factors capable of inducing
the inhibition.
Conditioned media of cultures from PECs from infected
mice, as well as from normal PECs treated with hemozoin
inhibited the IL-2 production by 1E5.11 T-cell hybridoma
(Table 4). No inhibition was observed when using condi-
tioned media from control PECs (data not shown).
Prostaglandins could be responsible for the deficient
T-cell hybridoma via their inhibitory effect on IL-2 production
by T-cells (Rappaport & Dodge 1982). The presence in
hemozoin of small amounts of free heme (Fitch & Kanja-
nanggulpan 1987) and the observation that free heme
activates the prostaglandin endoperoxide synthetase (Ueno
et al. 1982) led us to investigate the role of prostaglandins
on the observed immunosuppression. In general, treatment
of PECs from malaria-infected mice with indomethacin
(IM) during the antigen presentation assay did not restore
significantly the IL-2 production by the T-cell hybridoma
(P> 0·05) (Table 5). Only at the lowest PEC concentration, a
partial restoration of IL-2 production could be obtained by
addition of IM (P ¼ 0·02). Defective IL-2 production
induced by hemozoin-fed PECs or b-hematin fed PECs
was also insensitive to indomethacin. Again, only at the
lowest PEC concentration, and only in the case of hemozoin,
a partial restoration of IL-2 production could by obtained by
IM addition (P < 0·01). Thus, these results indicate that
prostaglandins are not the main cause of the impaired
malaria-associated accessory cell function.
Both PECs from P. chabaudi-infected mice or PECs
treated with hemozoin produced nitrite when cultured for
24 h. Nitric oxide has been shown to suppress IL-2 produc-
tion by T-cells (Taylor-Robinson 1997) and to inhibit the
T.Scorza et al. Parasite Immunology
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Table 3 Uptake and catabolism of protein antigen is not affected during acute P. chabaudi infection
Total associated % Total % Total
PECs radioactivityd Non-degradede radioactivity Degradedf radioactivity
Controla 6588 6 384 3879 6 384 58·8 6 7.4 2346 6 565 35·6 6 6.4
Infectedb 6549 6 119 4613 6 739 70·4 6 10 1706 6 424 26 6 6
Hemozoinc 6791 6 144 4447 6 544 65·4 6 9.4 2058 6 484 30·3 6 7.5
a,bPeritoneal exudate cells were harvested from non-infected mice and mice with acute parasitemia (32–38%). cPECs were treated with crude
hemozoin (10 mg/ml) overnight. dAfter 2 h of incubation with Na125I-labeled lysozyme, the PECs were washed extensively and the radioactivity
associated with the cells was measured. e,fThe incorporated radioactivity was measured after lysis with triton X-100 and treatment with 10%
tricloroacetic acid (TCA). The radioactivity associated with the TCA soluble (degraded lysozyme) and insoluble (non-degraded lysozyme)
fractions was measured separately. Values are expressed as means of triplicate measurements 6 SD.
Infection Hemozoin (lysate)
IL-2 production (pg/ml)a IL-2 production (pg/ml)b
PECs · 104/well Control +50% CM Control +50% CM
2·5 650 6 54 430 6 40 625 6 44 343 6 20
1·25 382 6 35 262 6 21 350 6 28 217 6 19
a,bIL-2 production (pg/ml) by the 1E5/11 T-cell hybridoma when naive PECs are used to
process/present HEL (10 mg/ml) in the presence of conditioned media (50% V/V) from 24-h
cultures of PECs from infected mice (32–40% parasitemia) or naive PECs treated with
hemozoin (10 mg/ml), respectively. Values are expressed as means of triplicate measurements
6 SD.
Table 4 Peritoneal macrophages from
P. chabaudi-infected mice or from PECs
treated with hemozoin produce soluble factors
that inhibit IL-2 production
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Table 5 Indomethacin does not correct significantly the malaria-associated defective accessory cell function
Infection Hemozoin (lysate) b-hematin
PECs · 104/well ¹IM þIM ¹IM þIM ¹IM þIM
5 71 6 5 68 6 8 84 6 6 73 6 5 90 6 8 89 6 4
2·5 61 6 10 41 6 8 92 6 7 61 6 21 89 6 5 79 6 7
1·25 76 6 9 47 6 101 90 6 5 54 6 112 88 6 6 78 6 8
Percentages of reduction in IL-2 production by the 1E5.11 T-cell hybridoma when processing/presentation of HEL is effectuated by PECs from
P. chabaudi infected mice (35% parasitemia), and PECs treated with crude hemozoin or b-hematin (10 mg/ml). Indomethacin (IM) was added at a
final concentration of 1 mmg/ml. Values are expressed as mean of triplicate measurements 6 SD. All P-Values > 0.05, except when indicated.
aP ¼ 0.02; bP < 0.01.
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Figure 2 Interleukin-2 production by the 1E5.11 T-cell hybridoma when using (a,c) nonfixed or (b,d) GA-fixed PECs as antigen-presenting cells.
The GA treatment was effectuated prior to the addition of (b) HEL-pep or (d) following incubation (3–4 h) with HEL.
binding of NF-kb factors to DNA (Matthews et al. 1996).
However, addition of aminoguanidine (a structural analogue
of L-arginine that inhibits the NO synthase), although
strongly decreasing NO production by the PECs, did not
alter the deficient T-cell activation (Table 6).
DISCUSSION
Numerous experimental observations suggest that during
malaria infections the accessory cell function of macro-
phages becomes defective, and that consequently, Plasmo-
dium infections may impair the optimal activation and
proliferation of T cells. Here, we show that during malaria
infections, peritoneal exudate cells (PECs) become defec-
tive in their capacity to stimulate an antigen specific T cell
hybridoma.
The first deficiency in the accessory cell function of PECs
seems to occur at the level of antigen processing. Indeed
impaired processing/presentation of the HEL protein was
already obvious with the PECs from moderate-infected mice
while impaired presentation of the HEL peptide occurred
mainly during the acute phase of the infection that corre-
sponds to the peak of parasitemia. The impaired presenta-
tion of the HEL peptide does not reflect a deficient
presentation capacity since GA treatment restored comple-
tely the ability of HEL peptide pulsed PECs from acutely
infected mice to stimulate the T cell hybridoma. Hence
Plasmodium infections do not alter the intrinsic antigenic
presenting capacity of PECs but rather modulate such cells
to actively suppress IL-2 production.
When PECs were incubated with lysozyme (3–4 h) prior
to fixation, the impaired IL-2 production induced by the
infection still persisted, indicating a blockage at the level of
antigen uptake/processing. However, protein antigen uptake
and catabolism by PECs from P. chabaudi-infected mice
was not affected. Taken together, these results suggest that
(1) a factor secreted by nonfixed PECs from malaria infected
mice plays a crucial role in the observed immunosuppres-
sion at acute parasitemias, and (2) that in addition late
steps of antigen processing subsequent to endocytosis and
catabolism seem also to be affected during both moderate
and acute Plasmodium infection stages. The infection could
hamper, for example, the formation of the adequate anti-
genic peptides, a process generated at multiple stages within
the endocytic and biosynthetic pathways. It has been
demonstrated for instance that processing of HEL is distinct
in early and late endocytic compartments, generating pep-
tides with different clonal specificities (Griffin et al. 1997).
In addition, loading of the adequate peptides to form
peptide:MHC-II complexes could also be affected during
the infection.
Conditioned media obtained from cultures of PECs from
acutely infected mice inhibited the IL-2 production by the
antigen-activated T-cell hybridoma. In respect to macro-
phage-derived inhibitory factors, reduced IL-2 responses
could be explained by the inhibitory activity of NO on the
DNA binding activity of the NF-kb transcription factor
family (Matthews et al. 1996). However, further investiga-
tion into the nature of the soluble secreted factor(s) involved
in the malaria induced immunosuppression excluded a role
for NO since the observed inhibition in IL-2 production was
refractory to aminoguanidine treatment. In addition indo-
methacin did not abrogate completely the defective IL-2
production. These two results contrast with two earlier
reports describing a correlation between the immunosup-
pressive role of macrophages during malaria infections and
the production of prostaglandin and NO (Rockett et al.
1994, Ahvazi et al. 1995). Thus, the nature of the soluble
factors secreted by PECs from malaria-infected mice and
responsible for the reduction of IL-2 secretion in the used
antigen presentation assays remains to be identified.
In order to unravel part of the biochemical mechanism
involved in malaria induced immunosuppression, attention
was paid to the parasite components responsible for the
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Infection Hemozoin (lysate)
PECs · 104/well ¹AMG þAMG ¹AMG þAMG
5 78 6 7 87 6 4 59 6 6 60 6 5
2·5 75 6 6 79 6 8 59 6 4 55 6 3
1·25 80 6 5 80 6 7 69 6 4 64 6 5
Percentages of reduction in IL-2 production by the 1E5.11 T-cell hybridoma when processing/
presentation of HEL is effectuated by PECs from P. chabaudi infected mice (35% parasitemia),
and PECs treated with crude hemozoin (10 mg/ml). Aminoguanidine (AMG) was added at a
final concentration of 1 mM. Values are expressed as mean of triplicate measurements 6 SD.
Table 6 Inhibition of nitric oxide production
does not restore the IL-2 production by the
T-cell hybridoma
observed effects. Since hemozoin is one of the most impor-
tant parasite catabolites and was suggested to be capable
to promote a defective antigen-processing presentation
(Morakote & Justus 1988), we further investigated its
effect in our antigen-presentation system. Similar to PECs
from malaria-infected mice that were shown to contain high
levels of hemozoin, hemozoin (or b-hematin)-fed PECs
were affected in their capacity to induce optimal IL-2
production by the T-cell hybridoma when the HEL protein
was used as antigen. Also, GA fixation of hemozoin-treated
PECs prior to addition of the HELpeptide, completely
abrogated the reduction in IL-2 production, suggesting an
active inhibition of IL-2 production by the pigment-loaded
macrophages. This inhibitory effect was never reported
before and was found to be independent of prostaglandin
or NO production by the hemozoin-fed macrophages. Inter-
estingly, NO production was not affected by treatment of
naive PECs with hemozoin, this in contrast to observations
described by Prada et al. (1996). These authors did not
specify the quantity of malaria pigment used in their
experiments to load the macrophages, and only describe
having added very high amounts of hemozoin. It is probable
that at very high concentrations, hemozoin can affect more
dramatically antimicrobial macrophages functions such as
phagocytosis and production of reactive nitrogen inter-
mediates. It seems that the mechanisms involved in the
malaria-induced immunosuppression can be mimicked by
loading naı¨ve PECs with crude hemozoin or with synthetic
b-hematin prior to antigen processing/presentation.
Although hemozoin was considered for several years as an
inert parasite catabolic product, it was shown to impair the
phagocytic capacity of human monocytes, as well as the
generation of phorbol-ester induced oxidative burst.
Furthermore, both the activity of protein kinase C and
NADPH-oxidase are drastically reduced in hemozoin-
loaded monocytes, while viability, ATP levels and protein
synthesis remained unaltered (Turrini et al. 1993).
The precise mechanism accounting for the suppressive
effects of hemozoin remains to be elucidated. In the
present study, we show that protein uptake and catabolism
are unaltered in hemozoin-treated macrophages, and are
therefore not the cause of the observed immunosuppres-
sion. Recent data demonstrate that hemozoin-loaded
monocytes exhibit markedly increased levels of lipo-
peroxides and of 4-hydroxynonenal (HNE), a very toxic
aldehyde originating from lipoperoxidation of unsaturated
fatty acids (Schwarzer et al. 1996). HNE was shown to
down-regulate PKC activity, and to reduce NADPH oxi-
dase activity and oxidative burst in hemozoin-loaded
monocytes. Considering that PKC exerts a vast number
of cellular functions (Nishizuka 1992), it will be of interest
to assess the effect of HNE in macrophage functions such
as antigen-processing/presentation, and their immuno-
modulatory properties.
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